Cetera Trust Company’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$375K Sell
3,656
-4,043
-53% -$457K 0.21% 90
2025
Q4
$965K Hold
7,699
0.52% 47
2025
Q3
$1.03M Hold
7,699
0.58% 46
2025
Q2
$1.05M Hold
7,699
0.63% 43
2025
Q1
$1.02M Hold
7,699
0.65% 40
2024
Q4
$871K Hold
7,699
0.57% 45
2024
Q3
$878K Hold
7,699
0.54% 46
2024
Q2
$800K Hold
7,699
0.5% 48
2024
Q1
$875K Hold
7,699
0.53% 47
2023
Q4
$847K Buy
+7,699
New +$769K 0.53% 47

Other funds holding ABT

Cetera Trust Company's ABT Position: Q1 2026 in Review

Cetera Trust Company reduced its Abbott (ABT) stake by 53% in Q1 2026, selling an estimated $457K and leaving 3,656 shares worth $375K. The position accounts for 0.21% of the portfolio, ranked #90.

Cetera Trust Company first reported a position in ABT in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.05M in Q2 2025. 3,089 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Cetera Trust Company held 3,656 shares of Abbott worth $375K as of Q1 2026.
  • Cetera Trust Company sold 4,043 Abbott shares in Q1 2026, an estimated $457K.
  • Abbott made up 0.21% of Cetera Trust Company's portfolio in Q1 2026, its #90 holding.
  • Cetera Trust Company first reported a position in Abbott in Q4 2023 and has held it in 10 quarters since.
  • Cetera Trust Company's Abbott position peaked at $1.05M in Q2 2025.
  • 3,089 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.